Andrew Blitzer
#162,058
Most Influential Person Now
Researcher
Andrew Blitzer's AcademicInfluence.com Rankings
Andrew Blitzercomputer-science Degrees
Computer Science
#9408
World Rank
#9882
Historical Rank
Machine Learning
#4108
World Rank
#4157
Historical Rank
Artificial Intelligence
#4448
World Rank
#4509
Historical Rank
Database
#6372
World Rank
#6605
Historical Rank
Download Badge
Computer Science
Andrew Blitzer's Degrees
- Masters Artificial Intelligence Stanford University
Similar Degrees You Can Earn
Why Is Andrew Blitzer Influential?
(Suggest an Edit or Addition)Andrew Blitzer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm (1987) (426)
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2008) (380)
- Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies–-Consensus Recommendations (2008) (324)
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study (2000) (307)
- Patient survival factors in paranasal sinus mucormycosis (1980) (263)
- Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia) (1988) (228)
- Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) (2008) (209)
- Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled Study (1994) (203)
- Botulinum toxin for the treatment of hyperfunctional lines of the face. (1993) (202)
- Botulinum Toxin: Basic Science and Clinical Uses in Otolaryngology (2001) (191)
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients (1998) (189)
- Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia (1989) (184)
- Age-Related Changes in Pharyngeal and Supraglottic Sensation (1994) (181)
- Laryngeal Dystonia: A Series with Botulinum Toxin Therapy (1991) (165)
- The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. (1997) (160)
- Air Pulse Quantification of Supraglottic and Pharyngeal Sensation: A New Technique (1993) (160)
- Research priorities in spasmodic dysphonia (2008) (142)
- Electromyographic Findings in Focal Laryngeal Dystonia (Spastic Dysphonia) (1985) (130)
- Recommendations of the Neurolaryngology Study Group on laryngeal electromyography (2009) (128)
- Use of Botulinum Toxin for Diagnosis and Management of Cricopharyngeal Achalasia (1997) (123)
- Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2008) (122)
- Semon's Law Revisited: An Electromyographic Analysis of Laryngeal Synkinesis (1996) (120)
- Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series (2010) (115)
- Speech dysfunction in early Parkinson's disease (1995) (107)
- Novel THAP1 sequence variants in primary dystonia (2010) (106)
- Treatment of Hyperfunctional Lines of the Face with Botulinum Toxin A (1998) (103)
- Abductor laryngeal dystonia: A series treated with botulinum toxin (1992) (103)
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients (1998) (97)
- Treatment of adductor laryngeal breathing dystonia with botulinum toxin type a (1994) (93)
- Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. (1986) (91)
- Clinical‐Pathological determinants in prognosis of fibrous histiocytomas of head and neck (1981) (89)
- Fungal infections of the nose and paranasal sinuses. Part I. (1993) (86)
- Malignant fibrous histiocytoma of the head and neck (1977) (82)
- Evaluation and Management of Bilateral Vocal Cord Immobility (1999) (81)
- Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. (1998) (80)
- Procedures for Administering Botulinum Toxin Type A for Migraine and Tension‐type Headache (2003) (79)
- Adductor laryngeal dystonia (spastic dysphonia): Treatment with local injections of botulinum toxin (Botox) (1989) (79)
- Surgery of the paranasal sinuses (1985) (78)
- Rhinocerebral mucormycosis: premortem diagnosis and therapy. (1979) (73)
- Laryngopharyngeal Dysfunction From the Implant Vagal Nerve Stimulator (2003) (71)
- Botulinum toxin treatment of adductor spasmodic dysphonia: Longitudinal functional outcomes (2011) (69)
- The emerging role of botulinum toxin in the treatment of temporomandibular disorders. (2007) (69)
- Treatment of focal dystonias with botulinum neurotoxin. (2009) (66)
- Craniofacial resection of ossifying fibromas and osteomas of the sinuses. (1989) (61)
- Vocal fold paresis: evidence and controversies (2007) (60)
- Movement disorders of the larynx (1992) (60)
- Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. (2012) (59)
- Enterogenous cyst of the orbital apex and superior orbital fissure. (1994) (58)
- Botulinum toxin for masseter reduction in Asian patients. (2004) (58)
- Botulinum toxin type A (BOTOX) for treatment of migraine. (2001) (55)
- Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin: Review and technical aspects (1992) (54)
- Voice Failure after Tracheoesophageal Puncture: Management with Botulinum Toxin (1995) (54)
- Adductor spasmodic dysphonia: standard evaluation of symptoms and severity. (1997) (53)
- Oromandibular dystonia: Long‐term management with botulinum toxin (2013) (52)
- Laryngeal botulinum toxin injections for disabling stuttering in adults (1994) (51)
- Botulinum Toxin A and B: A Comparative Dosing Study for Spasmodic Dysphonia (2005) (50)
- A new paradigm for the management of essential vocal tremor with botulinum toxin (2013) (50)
- Swallowing and Sensation: Evaluation of Deglutition in the Anesthetized Larynx (2002) (49)
- Botulinum toxin treatment for symptomatic Frey's syndrome (2000) (48)
- Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics (2014) (48)
- Botulinum toxin for the treatment of spasmodic dysphonia. (2000) (47)
- Botulinum toxin injections for lingual dystonia (1991) (46)
- Botulinum toxin for refractory vocal tics (1996) (45)
- The opacified maxillary sinus: CT findings in chronic sinusitis and malignant tumors. (1987) (45)
- Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30‐year experience (2018) (45)
- Sleep‐related laryngeal obstruction presenting as snoring or sleep apnea (1989) (44)
- Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection (2015) (44)
- SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea (2019) (44)
- Segmental hemangiomas of the upper airway (2009) (41)
- Neural correlates of abnormal sensory discrimination in laryngeal dystonia (2015) (41)
- Other noncosmetic uses of BOTOX. (2001) (41)
- Neurologic Disorders of the Larynx (2018) (41)
- Fungal infections of the nose and paranasal sinuses. Part II. (1993) (40)
- Mucoepidermoid carcinoma arising in an intraparotid lymph node (1985) (40)
- Noncosmetic uses of botulinum toxin. (2004) (39)
- An open‐label study of sodium oxybate in Spasmodic dysphonia (2017) (38)
- Electromyography and the immobile vocal fold. (2004) (38)
- Management of facial lines and wrinkles (1999) (37)
- Dyspnea in dystonia. A functional evaluation. (1995) (37)
- Oromandibular dystonia: Treatment of 96 patients with botulinum toxin A (1994) (37)
- Head and Neck: Editorial (2001) (37)
- Restoration of laryngopharyngeal sensation by neural anastomosis. (1997) (35)
- Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia (2010) (35)
- High-throughput mutational analysis of TOR1A in primary dystonia (2009) (33)
- A new treatment paradigm for trigeminal neuralgia using botulinum toxin type a (2014) (32)
- Foresight in Laryngology and Laryngeal Surgery: A 2020 Vision (2007) (32)
- Functional Anatomy and Oncologic Barriers of the Larynx. (2015) (28)
- IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder (2017) (28)
- Botulinum Toxin Management of Adductor Spasmodic Dysphonia after Failed Recurrent Laryngeal Nerve Section (2003) (28)
- Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders (1994) (27)
- The effect of indomethacin on the growth of epidermoid carcinoma of the palate in rats. (1983) (27)
- Surgical management of aspiration. (1988) (27)
- A short history of laryngoscopy. (1996) (27)
- Phenotype‐ and genotype‐specific structural alterations in spasmodic dysphonia (2017) (27)
- GNAL mutation in isolated laryngeal dystonia (2016) (26)
- Tympanic neurectomy and chorda tympanectomy for the control of drooling. (1978) (26)
- Approaches to the patient with aspiration and swallowing disabilities (1990) (26)
- Singer's Dystonia: First Report of a Variant of Spasmodic Dysphonia (2006) (26)
- Commentary on the role of expert opinion in developing evidence‐based guidelines (2014) (25)
- Botulinum toxin A: a novel method to remove periorbital wrinkles. (1994) (25)
- Botulinum toxin type A (BOTOX) for treatment of migraine. (2002) (24)
- Anesthesia for Laryngeal Surgery in the Office (2000) (24)
- BOTULINUM TOXIN TREATMENT OF TEMPOROMANDIBULAR DISORDERS, MASSETERIC HYPERTROPHY, AND COSMETIC MASSETER REDUCTION (2004) (24)
- The Caldwell-Luc Procedure in 1991 (1991) (24)
- Patient perceptions of factors leading to spasmodic dysphonia: A combined clinical experience of 350 patients (2011) (23)
- Management of Supraglottic Squeeze in Adductor Spasmodic Dysphonia: A New Technique (2007) (23)
- Central voice production and pathophysiology of spasmodic dysphonia (2018) (23)
- Vocal Fold Paresis of Charcot-Marie-Tooth Disease (2001) (23)
- A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia (2014) (23)
- Multilevel airway stenosis in patients with granulomatosis with polyangiitis (Wegener's). (2015) (23)
- Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia (2014) (22)
- The dystonic larynx (1992) (22)
- Collagenase in Human Head and Neck Tumors and Rat Tumors and Fibroblasts in Monolayer Cultures (1986) (22)
- The c.‐237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia (2011) (21)
- Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks. (2019) (21)
- Osteoblastoma of the ethmoid sinus: the fourth reported case. (1979) (21)
- Evaluation of tympanic neurectomy and chorda tympanectomy for gustatory sweating and benign salivary gland disease. (1978) (21)
- Inflammatory and Obstructive Disorders of Salivary Glands (1987) (21)
- Vocal Fold Paralysis: Causes, Outcomes, and Clinical Aspects (2006) (20)
- Cosmetic uses of botulinum neurotoxin type A: an overview. (2002) (19)
- Craniofacial Resection for Anterior Skull Base Tumors (1991) (19)
- Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15‐year experience (2016) (19)
- SIAXI (2019) (17)
- Development and validation of a new clinically-meaningful rating scale for measuring lateral canthal line severity. (2012) (17)
- Laryngeal manifestations of relapsing polychondritis and a novel treatment option. (2012) (17)
- Pathogenic variants in TUBB4A are not found in primary dystonia (2014) (16)
- Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. (2001) (16)
- Botulinum toxin: dangerous terminology errors. (1993) (15)
- A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity (2018) (15)
- Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients (2017) (14)
- Surgical therapy for swallowing disorders. (1998) (13)
- Office-based laser treatment of oral premalignant lesions (2011) (13)
- Office-based surgery in otolaryngology (1998) (13)
- Collagenase and Protease Activities in Head and Neck Tumors (1980) (13)
- Laryngeal neuropathy of Charcot‐Marie‐Tooth disease: Further observations and novel mutations associated with vocal fold paresis (2010) (13)
- Disorders with Excessive Muscle Contraction: Candidates for Treatment with Intramuscular Botulinum Toxin (“Botox”) (1993) (13)
- Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions. (2012) (13)
- Inflammatory and Obstructive Disorders of Salivary Glands (1987) (13)
- Soft Tissue Effects of the THC:YAG Laser on Canine Vocal Cords (1992) (12)
- Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia (2017) (11)
- Neurologic Evaluation of the Larynx and Pharynx (2010) (11)
- How I do it head and neck and plastic surgery: A targeted problem and its solution: Bilobed radial forearm free flap for functional reconstruction of near‐total glossectomy defects (1994) (11)
- Facial anatomy. (2004) (11)
- Nutritional considerations in the management of head and neck cancer patients. (1984) (10)
- Unearthing a consistent bilateral R1 component of the laryngeal adductor reflex in awake humans (2018) (10)
- Thyroid Carcinoma in a Patient with a Coexisting Functional Adenoma (1979) (10)
- Chemodenervation of the Larynx (2017) (10)
- Regional behavioral variations of epidermoid carcinoma of the head and neck: A study in an animal model (1982) (10)
- Delayed failure of myocutaneous flaps in head and neck reconstruction (1983) (10)
- Botulinum Toxin-A (BoNT-A) in Trigeminal Neuralgia (TN): Outcome of Placebo-Controlled RCT (2011) (9)
- Oromandibular Dystonia: A Clinical Examination of 2,020 Cases (2021) (9)
- Acoustic Assessment of Vocal Function (2009) (9)
- Other noncosmetic uses of BOTOX. (2002) (9)
- Granular Cell Tumors of the Larynx (1979) (8)
- Botulinum Neurotoxin for Head and Neck Disorders (2012) (8)
- Using botulinum toxin therapy in the laryngopharynx (2004) (8)
- Treatment of migraine headache with botulinum toxin type A. (2003) (7)
- Decision Points in the Management of Vocal Fold Paralysis (2006) (7)
- Hoarseness evaluation: A transatlantic survey of laryngeal experts (2014) (7)
- Mechanisms of spread of laryngeal carcinoma. (1979) (7)
- Botulinum toxin for the treatment of oromandibulolingual omd dystonia (1989) (7)
- Surgical Management of Airway Dysfunction in Parkinson's Disease Compared with Parkinson-Plus Syndromes (2013) (6)
- Diagnosis and Treatment of Laryngeal Dystonia: Past, Present and Future Directions (2016) (5)
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. (2010) (5)
- OFFICE-BASED DIRECT FIBEROPTIC LARYNGOSCOPIC SURGERY (1998) (5)
- Inflammation induced connective tissue breakdown following injury. (1984) (5)
- Foresight in Laryngology and Laryngeal Surgery: A 2020 Vision (2007) (5)
- Directed balloon cytology of the esophagus: A novel device for obtaining circumferential cytologic sampling (2017) (5)
- Association of Laryngeal Botulinum Neurotoxin Injection With Work Productivity for Patients With Spasmodic Dysphonia. (2021) (5)
- Laryngeal Dystonia Multidisciplinary Update on Terminology, Pathophysiology, and Research Priorities (5)
- Tuberculous peritonitis. A case report and review. (1976) (5)
- Dose Response of Topical Anesthetic on Laryngeal Neuromuscular Electrical Transmission (2005) (5)
- Adductor focal laryngeal Dystonia: correlation between clinicians’ ratings and subjects’ perception of Dysphonia (2017) (5)
- BOTULINUM TOXIN INJECTIONS FOR THE TREATMENT OF OROMANDIBULAR DYSTONIA (2004) (5)
- Laryngeal Sensory Receptors (2009) (5)
- Orofaciomandibular and lingual dystonia (Meige syndrome): Botulinum toxin treatment (1995) (5)
- Evaluation and Management of Chronic Aspiration (1987) (5)
- Percutaneous laryngeal electromyography for evaluation of neurogenic disorders, myopathies and spastic dysphonia (1985) (5)
- Evaluation of Tympanic Neurectomy and Chorda Tympanectomy Surgery (1978) (4)
- The emerging role of botulinum toxin type A in headache prevention (2004) (4)
- Botulinum toxin in the treatment of autonomic nervous system disorders (2004) (4)
- Surgical therapy for chronic aspiration (1997) (4)
- The Effect of Different Angiolytic Lasers on Resolution of Subepithelial Mucosal Hematoma in an Animal Model (2014) (4)
- Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter Reduction (2012) (4)
- Collagenase Activity in Squamous Cell Carcinoma of the Human Parotid Gland (1982) (4)
- Modification of the anterior commissure technique of partial laryngectomy. (1980) (4)
- IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial. (2022) (4)
- Negative dystonia of the palate: A novel entity and diagnostic consideration in hypernasal speech (2015) (4)
- Interesting case of late Gore‐Tex extrusion following medialization laryngoplasty (2018) (4)
- The traumatized auricle--care, salvage, and reconstruction. (1982) (4)
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. (2010) (4)
- CRICOPHARYNGEAL MUSCLE SPASMS AND DYSPHAGIA (1997) (4)
- Computed tomography of the cervical lymph nodes: use of intravenous contrast enhancement. (1983) (3)
- Noncosmetic uses of botulinum toxin. (2004) (3)
- Inflammatory and neoplastic lesions of the oral cavity. (1987) (3)
- Medical management of non-neoplastic salivary gland disease. (1984) (3)
- Management of hemifacial spasm and facial synkinesis with local injections of botulinum toxin (2004) (3)
- Botulinum neurotoxin A for the management of lower facial lines and platysma! bands (2002) (3)
- Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia (2016) (3)
- Laser photocoagulation in the care of patients with Osler-Weber-Rendu disease (1994) (3)
- Spasmodic Dysphonia: Focal Laryngeal Dystonia (2010) (3)
- Stroboscopic Examination of the Normal Larynx (2009) (2)
- Botulinum toxin treatment of upper esophageal sphincter hyperfunction (2004) (2)
- Botulinum toxin injection for the lower face and neck (2004) (2)
- Thorotrast-induced multiple carcinomatosis of the frontal sinus. (1980) (2)
- Bringing a new medical device to market. (2000) (2)
- Electromyography of Laryngeal and Pharyngeal Muscles (2009) (2)
- Impact of an Upper Respiratory Tract Infection on Botulinum Toxin Efficacy in Spasmodic Dysphonia Patients (2020) (2)
- Peripheral Laryngeal Motor Innervation (2009) (2)
- Oxford American handbook of otolaryngology (2008) (2)
- The saline challenge‐A test of injection laryngoplasty outcome (2018) (2)
- Laryngeal Function in Individuals With Parkinson's Disease (2005) (2)
- Botulinum toxin in the management of adductor and abductor spasmodic dysphonia (1993) (2)
- Vocal Fold Medialization , Arytenoid Adduction , and Reinnervation (2009) (2)
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. (1988) (2)
- Transnasal endoscopic laser surgery for the treatment of benign nasopharyngeal lesions (1994) (2)
- SIAXI: IncobotulinumtoxinA for sialorrhea in Parkinson’s disease, stroke, and other etiologies-Phase 3 Results (S30.007) (2018) (1)
- Botox for Migraine Headaches and Facial Pain (2018) (1)
- Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea (2018) (1)
- Medialization Thyroplasty Using the VoCoM Vocal Cord Medialization System (2006) (1)
- In Reference to “Partial Epiglottoplasty for Pharyngeal Dysphagia due to Cervical Spine Pathology” (2016) (1)
- Laryngeal, Pharyngeal and Respiratory Involvement in Palatal Tremor (2022) (1)
- Glomus Vagal Tumors (1988) (1)
- Speech Treatment for Neurologic Disorders (2009) (1)
- Flexible Endoscopic Evaluation of Swallowing with Sensory Testing (FEESST) (2009) (1)
- Immediate silastic® surgical obturator (1983) (1)
- Palatal myoclonus: treatment with botulinum toxin (2004) (1)
- Physical Examination of the Larynx and Videolaryngoscopy (2009) (1)
- Laryngectomy for aspiration: Narrow field technique (1997) (1)
- Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report (2020) (1)
- Efficacy of incobotulinumtoxinA in subjects with sialorrhea, assessed using the modified radboud oral motor inventory for Parkinson's disease (mROMP) (2018) (1)
- The Effectiveness of Using Laryngeal Electromyography Guidelines for Injection Augmentation. (2015) (1)
- Neurologic Disorders of the Larynx: E-Book (2015) (1)
- Hoarseness (2010) (1)
- Abductor spasmodic dysphonia (1993) (1)
- Correction of Facial Asymmetry (2017) (0)
- Poster 68: IncobotulinumtoxinA for Sustained Improvement in Sialorrhea in Parkinson's Disease, Stroke, and Other Etiologies: Long‐term Results from a Phase 3 Study (2018) (0)
- Polyp within the Center of a Vocal Fold Sulcus: A Proposed Pathophysiologic Construct (2016) (0)
- Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea: Results of the main phase of a phase 3 study (2018) (0)
- Management of Spasmodic Dysphonia with Botulinum Toxin (1995) (0)
- Management of abductor spasmodic dysphonia and oral mandibular dystonia (2010) (0)
- 464 Kikuchi-fujimoto lymphadenitis: a case report and review of literature (2018) (0)
- Saturday, October 2, 1993 (1993) (0)
- Thulium Laser Dacryocystorhinostomy for Symptomatic Epiphora (2011) (0)
- Tumor Growth and Extension in the Larynx (1988) (0)
- Safety and Feasibility of a Novel Esophageal Balloon for Circumferential Cytologic Sampling (2020) (0)
- 28. Treatment of laryngeal disorders and oromandibular dystonia: techniques of localization and dosing (2015) (0)
- Laryngeal Dysfunction in Sleep (2009) (0)
- Hyperfunctional Facial Lines (2012) (0)
- Model of a New Generation of Tracheostomy and Endotracheal Tubes (1988) (0)
- Conservation surgery of the head and neck via a craniofacial approach. (1986) (0)
- Rehabilitation of the head and neck cancer patient: Psychosocial aspects (1985) (0)
- Pharmacotherapy and trigeminal neuralgia. (1969) (0)
- expandable device for collecting tissue from a body lumen aerodigestive (2012) (0)
- Computer Documentation: Presentation and Image Data Base Systems (1995) (0)
- Diagnosis and management of dysphagia (2008) (0)
- Comprar Oxford American Handbook of Otolaryngology | Andrew Blitzer | 9780195343373 | Oxford University Press (2010) (0)
- Botulinum Toxin A and B: Comparative Dosing for Spasmodic Dysphonia (2004) (0)
- Laryngology/Broncho-Esophagology (2019) (0)
- Primary Odontogenic Tumors Manifesting as Isolated Soft Tissue Masses (2003) (0)
- • Neurolaryngology Subcommittee: Head and Neck Manifestations of Movement Disorders (With Spanish translation) (1997) (0)
- Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies—-Consensus Recommendations (2008) (0)
- Botulinum Toxin Therapy for Spasmodic Dysphonia Recurring After Nerve Resection (1989) (0)
- Anatomy of the Larynx (2009) (0)
- In response to Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics (2015) (0)
- Acknowledgement of Reviewers 2013 (2014) (0)
- Utilization of Botulinum Neurotoxin Therapy in the Laryngopharynx (2012) (0)
- Discussion: Oromandibular dystonia treated with botulinum toxin: Report of case (1995) (0)
- Evaluation and management of swallowing and voice disorders (1999) (0)
- Office-Based Laser Surgery Oto-Rhino-Laryngology (1995) (0)
- Meige′s Syndrome (2012) (0)
- Phenomenological Classification of Laryngeal Hyperadduction Revisited (2019) (0)
- Upper and Lower Esophageal Spasm (2012) (0)
- Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea (2018) (0)
- Dacryocystorhinostomy with a Thulium:YAG Laser—a Case Series (2018) (0)
- Hoarseness: The ABEA and ALA Perspective (2010) (0)
- Spasmodic dysphonia (1994) (0)
- Chapter 16 – Treatment of Oromandibular Dystonia, Bruxism, and Temporomandibular Disorders with Botulinum Toxin (2009) (0)
- Botulinum toxin treatment for a patient with Tourette's syndrome (2000) (0)
- SIAXI: IncobotulinumtoxinA for Sialorrhea in Parkinson's Disease, Stroke, and Other Etiologies-Phase III Results (2017) (0)
- Photodynamic Therapy for Treatment of Head and Neck Cancer: A Preliminary Report (1988) (0)
- Subcommittee on Neurolaryngology (1995) (0)
- Delineation of the Clinical Features and Treatment Response of Oromandibular Dystonia: A Multicenter Summary of 2,057 Cases. (2020) (0)
- Botulinum Toxin-Reply (1995) (0)
- Commentary on “Bilateral cerebellar stroke presenting with acute dysphonia and late palatal tremor” (2012) (0)
- Botox: Its Use in Facial Lines and Wrinkles (2009) (0)
- Pulmonary Function Evaluation (2009) (0)
- Central Laryngeal Motor Innervation (2009) (0)
- Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions (2020) (0)
- Hemifacial Spasm and Facial Synkinesis (2012) (0)
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. (2010) (0)
- Neurolaryngology subcommittee: Laryngeal reinnervation: Does it work? (1999) (0)
- Long-term experience with BoNT for spasmodic dysphonia (2016) (0)
- Oromandibular Dystonia in Cerebrotendinous Xanthomatosis (2009) (0)
- Spasmodic Dysphonia and Vocal Tremor (2021) (0)
- A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity (2018) (0)
- How to Do Philosophical Things With Words in advance (2021) (0)
- Pharmacology of Botulinum Neurotoxins (2012) (0)
- Chronic Tension Headache (2012) (0)
- Long-term Efficacy and Safety of IncobotulinumtoxinA Treatment for Sialorrhea (S4.007) (2019) (0)
- Steering Sheath for 2-Nostril Transnasal Office Laryngoscopy (2018) (0)
- Metformin for the Treatment of Recurrent Respiratory Papillomatosis. (2022) (0)
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. (2010) (0)
- Management of abductor spasmodic dysphonia (2010) (0)
- Comprar Neurologic disorders of the larynx | Mitchell F. Brin | 9781588904980 | Thieme (2009) (0)
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. (2010) (0)
- A Pilot Study of Quantitative Measurements of Nasal Function in Rhinitis and the Therapeutic Effects of Botulinum Toxin (2014) (0)
- Sialorrhea and Frey’s Syndrome (2007) (0)
- Treatment of migraine headaches with botulinum toxin A (1999) (0)
- Movement Disorder Emergencies of the Upper Aerodigestive Tract (2013) (0)
- Poster 471: SIAXI: Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Sialorrhea in Parkinson's Disease (PD), Stroke, and Other Neurological Conditions: Results of a Phase III, Placebo‐Controlled, Randomized, Double‐Blind Study (2017) (0)
- Vascular Lesions of the Upper Airway: Characterization of Anatomic Distribution (2009) (0)
- Comprar Botulinum Neurotoxin for Head and Neck Disord | Andrew Blitzer | 9781604065855 | Thieme (2012) (0)
- SIAXI: Efficacy and safety of Xeomin (incobotulinumtoxinA) for the treatment of sialorrhea in Parkinson’s disease (PD) and other neurological conditions: Results of a Phase III, placebo-controlled, randomized, double-blind study (S2.007) (2018) (0)
- Anterior Cranial Base Reconstruction (1988) (0)
- Dysphagia Following Pharyngeal Cancer Surgery (1996) (0)
- Frey′s Syndrome (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew Blitzer?
Andrew Blitzer is affiliated with the following schools:
